91 filings
8-K
IPIX
Innovation Pharmaceuticals Inc.
1 Feb 24
Departure of Directors or Certain Officers
8:30am
8-K
IPIX
Innovation Pharmaceuticals Inc.
5 Dec 23
Termination of a Material Definitive Agreement
4:25pm
8-K
IPIX
Innovation Pharmaceuticals Inc.
30 Oct 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
IPIX
Innovation Pharmaceuticals Inc.
4 Jan 23
Other Events
4:16pm
8-K
IPIX
Innovation Pharmaceuticals Inc.
15 Jun 22
Entry into a Material Definitive Agreement
4:00pm
8-K
yls fyaxev0etv
14 Oct 21
Departure of Directors or Certain Officers
5:00pm
8-K
x7mw1y9u2itjagvgqp0
15 Jan 21
Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives
12:35pm
8-K
9yt7n izczxb1myxe
22 Dec 20
FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals’ Brilacidin for Treating COVID-19
9:00am
8-K
z7ryqdzjazatkm1e9cts
10 Dec 20
Entry into a Material Definitive Agreement
12:00am
8-K
l5r vldgbo
16 Nov 20
Innovation Pharmaceuticals Announces Overseas Regulatory Filing Submitted For COVID-19 Clinical Study
12:47pm
8-K
n4twhp exjic
2 Nov 20
Regulation FD Disclosure
12:00pm
8-K
5n2s0
2 Oct 20
Innovation Pharmaceuticals Announces Pre-IND Meeting Request Granted by FDA for the Study of Brilacidin for the Treatment of COVID-19
12:00pm
8-K
tp9pizcp 2i
15 Sep 20
Laboratory Testing of Brilacidin for COVID-19 in Combination with Remdesivir Reduces Viral Load by Nearly 100 Percent
10:00am
8-K
o826rlol 56ocgfq
4 Aug 20
Innovation Pharmaceuticals and U.S. Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing
9:29am
8-K
sk089xudnxi4saa
22 Jul 20
Regulation FD Disclosure
10:00am
8-K
1rs6i4
20 Jul 20
Regulation FD Disclosure
3:09pm
8-K
pgf0d489c gi
19 Jun 20
Regulation FD Disclosure
5:27pm
8-K
5n4ziuqc33
26 May 20
Innovation Pharmaceuticals Receives Data from Public Health Research Institute Showing Brilacidin Inhibits SARS-CoV-2 (COVID-19) in a Human Cell Line
2:15pm
8-K
f6kbr 8n336v6
21 May 20
Regulation FD Disclosure
9:32am
8-K
jt1 c54o00
28 Apr 20
Innovation Pharmaceuticals Informed Next Phase of Brilacidin Coronavirus (COVID-19) Testing to Begin Week of May 4
9:30am